![Yuan Xu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 10 316 $ al 31/01/2026
Yuan J.
Xu is currently an Independent Director at Fate Therapeutics, Inc. since 2021 and an Independent Director at Xilio Therapeutics, Inc. since 2022.
Former positions include Chief Executive Officer & Director at Legend Biotech Corp.
from 2018 to 2020, Independent Director at Akero Therapeutics, Inc. from 2021 to 2025, Vice President-Biologics at Gilead Sciences, Inc. from 2014 to 2015, Senior Vice President at Merck & Co., Inc. from 2015 to 2017, and Vice President at Novartis AG from 2008 to 2014.
Education includes a doctorate from the University of Maryland and an undergraduate degree from Nanjing University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
FATE THERAPEUTICS, INC. 0,01 % | 29/05/2025 | 8.669 ( 0,01 % ) | 10 316 $ | 31/01/2026 |
LEGEND BIOTECH CORP. -.--% | 08/06/2020 | 0 ( -.--% ) | - $ | 31/01/2026 |
| 02/01/2026 | 0 ( -.--% ) | - $ | 31/01/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| FATE THERAPEUTICS, INC. | Director/Miembro de la Junta | 03/08/2021 |
| XILIO THERAPEUTICS, INC. | Director/Miembro de la Junta | 04/01/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Director/Miembro de la Junta | 09/12/2025 |
| LEGEND BIOTECH CORPORATION | Director Ejecutivo | 01/08/2020 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/08/2017 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/08/2015 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | |
Merck & Co., Inc.
 Merck & Co., Inc. Manufactures human and animal health pharmaceutical products & vaccines | |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University
 Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Legend Biotech Corp.
 Legend Biotech Corp. Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Develops therapies for patients with metabolic diseases |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
MarketScreener is also available in this country: United States.
Switch edition
